Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Conference Call February 10, 2025 8:00 AM ET
Company Participants
Ben Strain – Associate Vice President, Investor Relations
Herve Hoppenot – Chief Executive Officer
Pablo Cagnoni – President, Head of Research & Development
Christiana Stamoulis – Chief Financial Officer
Matteo Trotta – Executive Vice President, General Manager, U.S. Dermatology
Conference Call Participants
Tazeen Ahmad – Bank of America
David Lebowitz – Citibank
Jessica Fye – JPMorgan
Salveen Richter – Goldman Sachs
James Shin – Deutsche Bank
Vikram Purohit – Morgan Stanley
Marc Frahm – TD Cowen
Kelly Shi – Jefferies
Brian Abrams – RBC Capital Markets
Jay Olson – Oppenheimer
Matt Phipps – William Blair
Andrew Berens – Leerink Partners
Andy Chen – Wolfe Research
Salim Sayed – Mizuho
Evan Seigerman – BMO Capital Markets
Srikripa Devarakonda – Truist Securities
Operator
Greetings, and welcome to the Incyte Fourth Quarter 2024 and Full Year Financial and Corporate Update Conference Call and Webcast. At this time all participants are in listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It’s now my pleasure to turn the call over to Ben Strain, Associate Vice President of Investor Relations. Please go ahead, Ben.
Ben Strain
Thank you, Kevin. Good morning and welcome to Incyte’s fourth quarter and full-year 2024 earnings conference call.
Before we begin, I encourage everyone to go to the Investors section of our website to find the press release, related financial tables and slides that follow today’s discussion. On today’s call, I’m joined by Herve, Pablo, Christiana, who will deliver the prepared remarks. Matteo and Steven will also be available for Q&A.
I would like to point out that we’ll be making forward-looking statements which are based on our current expectations and
Credit: Source link
